Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Formula: C24H23N5O2
displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia
G-Strophanthin
It acts by selectively blocking proliferation of drug-resistant ERα-positive breast and ovarian cancer cells
selective A2AR antagonist
MDA 19 Size:Solid 10 mg Formula: C24H23N5O2MDA19 or MDA 19 is discontinued (DEA controlled substance). It is a selective agonist of the human peripheral cannabinoid (CB2) receptor, with an EC50 value for activation (63. 4 nM) that is 14 fold lower than that for central cannabinoid (CB1) activation (EC50 = 867 nM). MDA19 exhibited a distinctive in vitro functional profile at rat CB2 receptors and behaved as a CB1 CB2 agonist in vivo, characteristics of a protean agonist. MDA19 has potential for
US$ 48.00
US$ 65.00
US$ 75.00